What is the projected CAGR at which the Rare Disease Genetic Testing Market is expected to grow at?

The Rare Disease Genetic Testing Market is expected to grow at a CAGR of 13.1% (2023-2032).

What is the size of the Rare Disease Genetic Testing Market in 2023?

The Rare Disease Genetic Testing Market size is USD 918.94 million in 2023.

Which region is more appealing for vendors employed in the Rare Disease Genetic Testing Market?

In 2022, North America led the global industry with a share of more than 47.2%.

Name the key business areas for the Rare Disease Genetic Testing Market.

The US, Canada, China, India, Brazil, South Africa, Singapore, Indonesia, Portugal, etc., are leading key areas of operation for the Rare Disease Genetic Testing Market.

List the segments encompassed in this report on the Rare Disease Genetic Testing Market?

Market.US has segmented the Rare Disease Genetic Testing Market by geography (North America, Europe, APAC, South America, And Middle East and South Africa). The market has been segmented Based on Disease Type Endocrine & Metabolism Diseases, Immunological Disorders, Neurological Disease, Hematology Diseases, Cancer, and Other Disease types. Based on Technology Next-Generation Sequencing( NGS), Array Technology, PCR-Based Testing, FISH, and Other Technology. Based on Specialty Molecular Genetic Tests, Chromosomal Genetic Tests, and Biochemical Genetic Tests. Based on End-User Research Laboratories & CROs, Hospitals & Clinics, Diagnostic Laboratories and Other End-Users.

Rare Disease Genetic Testing Market Size

Global Rare Disease Genetic Testing Market, By Disease Type (Endocrine & Metabolism Diseases, Immunological Disorders, Neurological Diseases, Hematology Diseases, Cancer, and Other Disease Types), By Technology, By Specialty, By End-User, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

- Get a FREE Sample -

Our Clients